← Leaderboards
Elisa Boscolo
Cincinnati Childrens Hosp Med Ctr
$6,135,991
Attributed
$6,135,991
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,135,991 · 2
By mechanism
R01$6,135,991 · 2
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Aaron M Zorn$31,248,424
- Matthew Tyson Weirauch$11,937,428
- Leah Claire Kottyan$13,264,157
- James M Wells$16,596,466
- Kenneth J Campbell$13,429,793
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularBlood VesselsMaintenanceCellsGeneticEndothelial CellsMutantLesionMutationTargeted TreatmentVeinsAngiogenesisBirthChronicVenousReceptor Protein-Tyrosine KinasesReportingSclerotherapyMouse ModelPainChildCell MotilityVenous MalformationPathologic
Grant awards (12)
Venous Malformations (VM): A Murine Mdoel to Identify Therapies to Target Aberrant Venous Development$636,000
R01 · FY2025 · HL · contact PI
Pathogenesis of Vascular Anomalies with GNAQ mutations$593,585
R01 · FY2025 · HL · contact PI
Venous Malformations (VM): A Murine Mdoel to Identify Therapies to Target Aberrant Venous Development$623,281
R01 · FY2024 · HL · contact PI
Pathogenesis of Vascular Anomalies with GNAQ mutations$608,559
R01 · FY2024 · HL · contact PI
Venous Malformations (VM): A Murine Mdoel to Identify Therapies to Target Aberrant Venous Development$636,000
R01 · FY2023 · HL · contact PI
Venous Malformations (VM): A Murine Mdoel to Identify Therapies to Target Aberrant Venous Development$636,000
R01 · FY2022 · HL · contact PI
Venous Malformations (VM): A Murine Mdoel to Identify Therapies to Target Aberrant Venous Development$636,000
R01 · FY2021 · HL · contact PI
Venous Malformations (VM): A Murine Mdoel to Identify Therapies to Targer Aberrant Venous Development$351,000
R01 · FY2017 · HL · contact PI
Venous Malformations (VM): A Murine Mdoel to Identify Therapies to Targer Aberrant Venous Development$351,000
R01 · FY2016 · HL · contact PI
Venous Malformations (VM): A Murine Mdoel to Identify Therapies to Targer Aberrant Venous Development$345,736
R01 · FY2015 · HL · contact PI
Venous Malformations (VM): A Murine Mdoel to Identify Therapies to Targer Aberrant Venous Development$343,980
R01 · FY2014 · HL · contact PI
Venous Malformations (VM): A Murine Model to Identify Therapies to Target Aberran$374,850
R01 · FY2013 · HL · contact PI